Eris Lifesciences

BSE: 540596 30 Sep 2025

Healthcare

₹ 1596.4

Eris Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Eris Lifesciences

BSE: 540596 30 Sep 2025

Healthcare

₹ 1596.4

Eris Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Book Value

210.0

Dividend Yield

0.46%

Debt to Equity

0.87

Stock P/E

55.8

Market Cap

21,597 Cr

Eris Lifesciences - Share Price & Details

Market Cap

₹21,597

High /Low

1,910 / 1,097

Stock P/E

55.8

Book Value

₹210.0

Dividend Yield

0.46

ROCE

12.2

ROE

₹12.9

Face Value

1.0

PEG Ratio

-11.3

EVEBITDA

₹22.4

Debt

2,478

CMP / FCF

90.3

Debt to equity

₹0.87

NP Ann

375

High price all time

1,910

Piotroski score

₹6.0

Graham Number

366.0

No. Eq. Shares

13.6

Net CF

₹105

Net profit

411

Price to book value

7.56

Interest Coverage

₹3.44

Low price all time

321.0

Industry PE

33.0

Reserves

₹2,841

Free Cash Flow

₹910

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
07 Aug 2025	Motilal Oswal	Hold	₹0	₹2,600	8.6%	moneycontrol	View
06 Aug 2025	Prabhudas Lilladher	Buy	₹1,809	₹1,975	14.5%	moneycontrol	View
06 Aug 2025	Motilal Oswal	Hold	₹1,725.45	₹1,700	-1.4%	moneycontrol	View
20 May 2025	Prabhudas Lilladher	Buy	₹1,468.75	₹1,740	15.5%	moneycontrol	View
19 May 2025	Motilal Oswal	Hold	₹1,443.45	₹1,350	-8.1%	moneycontrol	View
05 Feb 2025	Prabhudas Lilladher	Buy	₹1,231.55	₹1,450	4.3%	moneycontrol	View
04 Feb 2025	Motilal Oswal	Hold	₹1,231.55	₹1,270	-12.6%	moneycontrol	View
26 Oct 2024	Prabhudas Lilladher	Buy	₹1,293.2	₹1,420	-2.8%	moneycontrol	View
05 Aug 2024	Prabhudas Lilladher	Buy	₹1,078.65	₹1,250	-15%	moneycontrol	View
22 May 2024	Prabhudas Lilladher	Buy	₹908.15	₹1,100	-25.2%	moneycontrol	View
14 Mar 2024	Motilal Oswal	Hold	₹863.5	₹930	-36.7%	moneycontrol	View
23 Feb 2024	Prabhudas Lilladher	Buy	₹875.95	₹1,100	-25.2%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
Eris Lifesciences Limited	6013.2	999.9	5786.4	7.33	21,597	55.8
POLY MEDICURE LTD.	4251.42	879.29	3840.47	8.67	19855	55.5
NEULAND LABORATORIES LTD.	3006.09	137.08	2927.53	10.68	17918	136.0

Peer Comparison Chart

About Eris Lifesciences

Eris Lifesciences Limited, with Security Code 540596, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

The total return for Eris Lifesciences (NSE:ERIS) investors has risen faster than earnings growth over the last five years

(18 Sep 2025)

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

Is Eris Lifesciences Limited (NSE:ERIS) Worth ₹1.8k Based On Its Intrinsic Value?

(01 Sep 2025)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Eris Lifesciences fair value estimate is ₹1365 Eris...

Eris Lifesciences' Ahmedabad-based unit gets regulatory approval from Brazil's ANVISA

(25 Aug 2025)

Eris Lifesciences said that its manufacturing unit at the company's Ahmedabad campus has received approval from ANVISA, which is Brazil's...

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	314.6	411.3	409.7	324.4	341.3	456.7	428.8	399.7	404.8	578.6
Expenses	203.1	255.8	265.2	250.0	261.9	333.3	293.9	300.2	283.8	362.3
Operating Profit	111.5	155.5	144.5	74.4	79.4	123.4	134.8	99.6	121.0	216.3
OPM %	35.44%	37.81%	35.27%	22.94%	23.26%	27.02%	31.44%	24.91%	29.9%	37.38%
Other Income	4.3	4.0	7.0	3.4	20.4	5.2	13.6	7.8	16.8	22.7
Interest	3.0	6.8	6.5	15.1	28.9	56.2	56.3	54.7	53.2	45.1
Depreciation	17.3	20.2	25.0	28.1	29.1	45.6	46.2	46.7	43.4	37.6
Profit before tax	95.5	132.5	119.9	34.6	41.7	26.8	46.0	6.0	41.2	156.3
Tax %	-8%	-16.4%	-1.8%	-8.6%	-5.4%	36.5%	-38.9%	-70.5%	-26%	36%
Net Profit	87.8	110.7	117.8	31.7	39.5	17.0	28.1	1.8	30.5	100.0
EPS in Rs	6.43	8.13	8.65	2.33	2.9	1.25	2.06	0.13	0	7.33

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	423.3	402.8	466.6	505.3	486.3	550.9	719.7	739.0	727.5	705.3
Expenses	286.1	283.9	296.9	324.2	310.8	402.5	469.7	476.7	477.1	452.9
Operating Profit	137.2	118.9	169.7	181.1	175.5	148.4	250.0	262.3	250.3	252.4
OPM %	32.42%	29.52%	36.38%	35.85%	36.09%	26.94%	34.73%	35.49%	34.41%	35.79%
Other Income	2.2	1.0	1.0	3.5	4.2	15.1	1.6	6.8	4.2	8.0
Interest	3.0	8.9	17.4	16.3	18.1	33.0	60.4	59.5	57.2	54.3
Depreciation	29.9	35.1	40.9	42.1	45.7	53.9	75.9	80.5	81.2	77.3
Profit before tax	106.5	75.9	112.5	126.2	115.9	76.6	115.3	129.1	116.2	128.9
Tax %	-5.9%	-19%	-16.7%	-3.1%	-12.4%	3.9%	-22.5%	25.4%	25.2%	-20.6%
Net Profit	100.2	61.5	93.6	122.3	101.5	79.6	89.4	96.4	86.9	102.4
EPS in Rs	7.49	4.79	6.97	9.06	7.54	5.21	6.1	6.72	6.14	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	12%
5 Years:	11%
3 Years:	12%
TTM:	14%

Compounded Profit Growth
10 Years:	0%
5 Years:	-23%
3 Years:	-43%
TTM:	-74%

Stock Price CAGR
10 Years:	0%
5 Years:	25%
3 Years:	29%
1 Year:	67%

Compounded Sales Growth
10 Years:	18%
5 Years:	22%
3 Years:	29%
TTM:	44%

Compounded Profit Growth
10 Years:	15%
5 Years:	4%
3 Years:	-5%
TTM:	-10%

Stock Price CAGR
10 Years:	0%
5 Years:	25%
3 Years:	29%
1 Year:	67%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

Eris Lifesciences

Eris Lifesciences

Eris Lifesciences - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Eris Lifesciences

Order Book

Latest News

The total return for Eris Lifesciences (NSE:ERIS) investors has risen faster than earnings growth over the last five years

Is Eris Lifesciences Limited (NSE:ERIS) Worth ₹1.8k Based On Its Intrinsic Value?

Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis Deal

Eris Lifesciences receives ANVISA approval at its Ahmedabad campus

Eris Lifesciences Gets ANVISA Approval for Ahmedabad Unit

Eris Lifesciences' Ahmedabad-based unit gets regulatory approval from Brazil's ANVISA

Eris Lifesciences receives ANVISA approval for Ahmedabad Sterile Injectable facility

Eris Lifesciences' unit gets Brazil health regulator nod

Eris Lifesciences gets ₹17 crore GST show cause notice over Novartis trademark deal

Eris Lifesciences to meet investors in Singapore and Hong Kong

Eris Lifesciences reports 41% year-on-year rise in net profit in Q1

Eris Lifesciences betting on insulin expertise to boost its GLP-1 play | Company Business News

Eris Lifesciences eyes ‘good’ share in semaglutide generics, says COO

Eris Lifesciences Limited (ERIS) vs yyy - Exponential wealth increase

Can Eris Lifesciences Limited (ERIS) Maintain Its Valuation - Breakout stock performance

Can Eris Lifesciences Limited (ERIS) Maintain Its Valuation - Record-breaking capital gains

Eris Lifesciences Limited (ERIS) Hits 52 Week High - Consistent double returns

Eris Lifesciences Limited (ERIS) Hits 52 Week High - Triple-digit returns

Eris Lifesciences Limited (540596)’s Trend in 2025 - Free Consultation

Macro Trends and Their Impact on Eris Lifesciences Limited (540596) - Outstanding yields

Is Eris Lifesciences Limited (ERIS) a Good Long Term Bet - Explosive trading opportunities

Eris Lifesciences Limited (ERIS) vs yyy - Phenomenal wealth increase

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 26%

Eris Lifesciences - At multi-year highs: These 7 stocks witness 5-year swing high breakout

Stocks To Buy: Gillette India, Eris Lifesciences, Tata Motors, Power Grid Corp, Makind Pharma

Breakout Stocks: How to trade GE Vernova, Bharat Dynamics & Eris Lifesciences that hit fresh 52-week high?

Eris Lifesciences' (NSE:ERIS) Conservative Accounting Might Explain Soft Earnings

Eris Lifesciences Share Price Today - Eris Lifesciences Stock Price Live NSE/BSE

Earnings Miss: Eris Lifesciences Limited Missed EPS By 5.9% And Analysts Are Revising Their Forecasts

ERIS LIFESCIENCES TO HOLD BOARD MEETING

Buy Eris Lifesciences; target of Rs 1740: Prabhudas Lilladher

Eris Lifesciences rises 4% on posting Q4 results; Check all details here

ERIS Lifesciences Shows Strong Resilience Amid Market Downturn with Notable Stock Reversal

Eris Lifesciences gains after Q4 PAT climbs 32% YoY to Rs 94 cr

Eris Lifesciences Q4 profit rises 31%, EBITDA margin expands to 36%

Stock Recommendations Today: HAL, Eris Lifesciences, Hyundai Motor, Divis Labs On Brokerages Radar

DIARY-India economic, corporate events on May 19

Mr Ganesh Boddu, GM- Regulatory Affairs & Clinical Research, Eris LifeSciences

ERIS Lifesciences to hold board meeting

Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

JSA advises Levim Lifetech on sale of 30% stake to Eris Lifesciences

Eris Lifesciences Appoints Gopal Agrawal & Nita Borkar To Key Leadership Roles

Shipping Corporation, Eris Lifesciences, KEI Industries: Check the top high-volume stocks of the day

Eris Lifesciences appoints Gopal Agrawal and Nita Borkar to leadership roles

Can Mixed Fundamentals Have A Negative Impact on Eris Lifesciences Limited (NSE:ERIS) Current Share Price Momentum?

Eris Lifesciences transfers ₹861.91 crore holdings to subsidiary as part of internal restructuring

Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business

Eris Lifesciences appoints Murari Ranganathan as president, cardiometabolic business

Eris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore

Eris Lifesciences Sells Entire Stake In Its Subsidiaries For Rs 861.9 Crore

Eris Lifesciences appoints Murari Ranganathan as president of Cardiometabolic Business

ERIS Lifesciences Faces Significant Stock Decline Amid Broader Market Volatility

Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance

HCL Technologies, Dabur India, Eris Lifesciences: How to trade these buzzing stocks

What You Can Learn From Eris Lifesciences Limited's (NSE:ERIS) P/E

Eris Lifesciences Limited's (NSE:ERIS) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

ERIS LIFESCIENCES Share Price Today Down 3%

Breakout Stocks: How to trade Vedanta, Swan Energy and Eris Lifesciences on Thursday

ERIS Lifesciences Reaches 52-Week High, Outperforms Sector and Market Averages

ERIS Lifesciences Stock Sees 4.91% Increase, Hits New High Amidst Strong Performance

ERIS Lifesciences Stock Sees 3.69% Increase, Outperforms Sector and Sensex

ERIS Lifesciences Hits 52-Week High, Outperforms Sector with Strong Performance

ERIS Lifesciences' Stock Performance Reflects Strong Presence in Largecap Pharma Industry

ERIS Lifesciences Sees 6.52% Increase in Stock Price, Outperforms Sector and Sensex

Trade Spotlight: How should you trade TCS, HDFC Bank, CIE Automotive, Afcons Infrastructure, Eris...

ERIS LIFESCIENCES Share Price Today Up 4%

MarketTradingGuide: Ramco Cements among 2 stock recommendations for Wednesday

ERIS Lifesciences Stock Sees 5.28% Increase, Outperforms Sector by 3.04% on November 12

Market Trading Guide: Ramco Cements among 2 stock recommendations for Wednesday